GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (FRA:NZM2) » Definitions » Cyclically Adjusted PB Ratio

Novonesis AS (FRA:NZM2) Cyclically Adjusted PB Ratio : 9.27 (As of Jun. 10, 2024)


View and export this data going back to . Start your Free Trial

What is Novonesis AS Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Novonesis AS's current share price is €56.26. Novonesis AS's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €6.07. Novonesis AS's Cyclically Adjusted PB Ratio for today is 9.27.

The historical rank and industry rank for Novonesis AS's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:NZM2' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.23   Med: 9.69   Max: 13.83
Current: 9.36

During the past years, Novonesis AS's highest Cyclically Adjusted PB Ratio was 13.83. The lowest was 6.23. And the median was 9.69.

FRA:NZM2's Cyclically Adjusted PB Ratio is ranked worse than
94.18% of 1202 companies
in the Chemicals industry
Industry Median: 1.66 vs FRA:NZM2: 9.36

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Novonesis AS's adjusted book value per share data for the three months ended in Dec. 2023 was €6.763. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.07 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novonesis AS Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Novonesis AS's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Cyclically Adjusted PB Ratio Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.19 9.42 13.63 7.97 8.23

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.97 7.81 7.09 6.28 8.23

Competitive Comparison of Novonesis AS's Cyclically Adjusted PB Ratio

For the Specialty Chemicals subindustry, Novonesis AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Cyclically Adjusted PB Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Cyclically Adjusted PB Ratio falls into.



Novonesis AS Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Novonesis AS's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=56.26/6.07
=9.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis AS's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Novonesis AS's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.763/116.7000*116.7000
=6.763

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

Book Value per Share CPI Adj_Book
201403 5.471 99.600 6.410
201406 5.574 99.700 6.524
201409 5.843 99.700 6.839
201412 5.951 99.400 6.987
201503 4.901 100.200 5.708
201506 4.898 100.300 5.699
201509 4.884 100.200 5.688
201512 5.113 99.800 5.979
201603 4.709 100.200 5.484
201606 4.899 100.600 5.683
201609 4.927 100.200 5.738
201612 5.299 100.300 6.165
201703 4.952 101.200 5.710
201706 4.856 101.200 5.600
201709 4.907 101.800 5.625
201712 5.162 101.300 5.947
201803 4.696 101.700 5.389
201806 4.948 102.300 5.644
201809 5.080 102.400 5.789
201812 5.325 102.100 6.086
201903 5.083 102.900 5.765
201906 5.164 102.900 5.857
201909 5.292 102.900 6.002
201912 5.457 102.900 6.189
202003 5.106 103.300 5.768
202006 5.170 103.200 5.846
202009 5.202 103.500 5.865
202012 5.405 103.400 6.100
202103 5.191 104.300 5.808
202106 5.284 105.000 5.873
202109 5.616 105.800 6.195
202112 5.740 106.600 6.284
202203 5.485 109.900 5.824
202206 5.884 113.600 6.045
202209 6.639 116.400 6.656
202212 6.724 115.900 6.770
202303 6.255 117.300 6.223
202306 6.491 116.400 6.508
202309 7.010 117.400 6.968
202312 6.763 116.700 6.763

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novonesis AS  (FRA:NZM2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Novonesis AS Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (FRA:NZM2) Business Description

Industry
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (FRA:NZM2) Headlines

No Headlines